A Missouri senator recently opened an investigation into the pharmaceutical industry’s role in the nation’s burgeoning opioid addiction epidemic, but notably omitted one of the biggest opioid manufacturers from the probe. The company happens to be based in her home state.
The suit is part of an ongoing, two-year long antitrust investigation conducted by the U.S. Department of Justice.
A lawsuit filed Thursday in the U.S. District Court for the District of Connecticut alleges Heritage Pharmaceuticals, EpiPen-maker Mylan NV, and others conspired to manipulate U.S. drug prices. The suit was filed on behalf of the states of Connecticut, Delaware,